NIH Seeks Comments on Mental Health Archive
Published Date: 6/3/2026
Notice
Summary
The National Institute of Mental Health (NIMH) is asking for a 30-day public comment period to review and approve their data collection process for the Mental Health Data Archive. This affects researchers and anyone who shares mental health data with NIMH. Comments are due by June 3, 2026, and there’s no new cost involved—just keeping things clear and up-to-date!
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Researchers' 90‑Minute Data Forms
If you are a researcher who submits data to or requests access from the NIMH Data Archive (NDA), you must complete either a Data Submission Agreement (DSA) or a Data Use Certification (DUC). Each response takes about 90 minutes; there are an estimated 300 submitting researchers and 950 access-requesting researchers, for a total annualized burden of 1,875 hours. There are no monetary costs to respondents, OMB approval is requested for 3 years, the current control expires 2026-06-30, and comments are due by June 3, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14752, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in August 2026 to review and evaluate important grant and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding to fight antibiotic resistance, support schizophrenia research, and boost medical tech. If you’re involved in these fields, keep an eye on these dates—they could impact future research dollars and projects.
2026-14666, National Institute of Neurological Disorders and Stroke; Notice of Meeting
The National Institute of Neurological Disorders and Stroke is hosting a free, virtual meeting on August 24, 2026, to talk about Parkinson’s disease research, care, and services. This meeting affects people with Parkinson’s, their families, and organizations working on the disease, as it will share updates and plan a federal list of Parkinson’s programs. Public comments are welcome until August 10, giving everyone a chance to join the conversation and help shape future efforts.
2026-14346, Government Owned Invention Available for License: Selective Expansion of Engineered TCR-T Cells for Use in Adoptive Cell Immunotherapy
The National Cancer Institute has invented a cool new way to grow special immune cells called TCR-T cells that can better fight cancer. This method helps companies make more powerful, targeted cell therapies by boosting the right cells and cutting out the extras. If you’re in biotech or cancer treatment, this is your chance to license a game-changing tool that could speed up cancer cures and bring new treatments to patients faster.
2026-14347, Government Owned Invention Available for License: Method of Manufacturing Papilloma Infiltrating Lymphocyte (PIL) Cell Therapy Products as a Treatment for Patients With Chronic Viral Infection(s)
The National Cancer Institute has created a new way to make special immune cells called PILs that can fight chronic HPV infections causing painful growths in the throat and genital areas. This new cell therapy could reduce the need for repeated surgeries, improving patients’ lives and cutting healthcare costs. Researchers are now looking for partners to help develop and license this promising treatment soon.
2026-14242, National Institute on Minority Health and Health Disparities; Notice of Partially Closed Meeting
The National Institute on Minority Health and Health Disparities is holding a virtual meeting on August 31, 2026, to discuss important health topics and review grant applications. The first part of the meeting is open to the public and will be streamed online, while the last hour is closed to protect private info and trade secrets. This meeting affects researchers and communities focused on minority health and could influence future funding decisions.
2026-14133, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering new, powerful antibodies for licensing that help the immune system fight cancer better by releasing its natural brakes. This opportunity is perfect for companies ready to bring cutting-edge cancer treatments to market faster, with some international patent options available. Interested parties should act soon to explore this exciting tech and start making a difference—and money!
Previous / Next Documents
Previous: 2026-11043, Initiation of Section 301 Investigation and Request for Public Comments: Vietnam's Acts, Policies, and Practices Related to Intellectual Property Protection and Enforcement
The U.S. is launching an investigation into Vietnam for not protecting intellectual property rights fairly, which affects American businesses relying on these protections. This could lead to changes in trade rules or penalties if Vietnam doesn’t improve. Public comments are open until July 2, 2026, so anyone interested can share their thoughts before decisions are made.
Next: 2026-11046, Vanda Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Refuse To Approve a Supplemental New Drug Application for HETLIOZ (Tasimelteon)
Vanda Pharmaceuticals asked the FDA to approve a new use for their sleep drug HETLIOZ to treat jet lag, but the FDA said no and now there’s a public hearing to decide what’s next. This affects Vanda, travelers hoping for a jet lag fix, and could delay the drug’s availability while money and time are on the line. The hearing starts July 20, 2026, so mark your calendars!